We are determined to contribute to public health and
through our ongoing development of
innovative diagnostic technologies.
- In Vitro Diagnostic Reagents
- We provide high-quality clinical diagnostics reagents for autoimmune diseases and genetic testing, targeted for clinical laboratories and hospitals.
- Customized Companion Diagnostics
- To support drug development, MBL provides contract services for development of companion diagnostics.
Apr 05, 2021Recombinant Afamin/Wnt3a is now available!
This is the purified version of the popular product, Afamin/Wnt3a Conditioned Medium.
Feb 15, 2021Peptide Screening Kit newly join in the QuickSwitch™ series
For high-throughput peptide-MHC binding affinities evaluation. HLA-A*02:01 Monomer is contained in this Kit.
Feb 15, 2021QuickSwitch™ Quant HLA-A*03:01 Tetramer Kits are now available
For customizing MHC class I tetramer. A patented technique allows to exchange peptides on MHC. New allele, HLA-A*03:01, join in the series!!